317 related articles for article (PubMed ID: 8813725)
21. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter.
McAveney KM; Book ML; Ling P; Chebath J; Yu-Lee L
Mol Endocrinol; 2000 Feb; 14(2):295-306. PubMed ID: 10674401
[TBL] [Abstract][Full Text] [Related]
22. Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family.
Gourdou I; Gabou L; Paly J; Kermabon AY; Belair L; Djiane J
Mol Endocrinol; 1996 Jan; 10(1):45-56. PubMed ID: 8838144
[TBL] [Abstract][Full Text] [Related]
23. In vitro expression of long and short ovine prolactin receptors: activation of Jak2/STAT5 pathway is not sufficient to account for prolactin signal transduction to the ovine beta-lactoglobulin gene promoter.
Bignon C; Daniel N; Belair L; Djiane J
J Mol Endocrinol; 1999 Oct; 23(2):125-36. PubMed ID: 10514551
[TBL] [Abstract][Full Text] [Related]
24. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
Ali S; Ali S
J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
[TBL] [Abstract][Full Text] [Related]
25. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
26. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation.
Rycyzyn MA; Reilly SC; O'Malley K; Clevenger CV
Mol Endocrinol; 2000 Aug; 14(8):1175-86. PubMed ID: 10935542
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
28. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.
Fleenor DE; Freemark M
Endocrinology; 2001 Jul; 142(7):2805-10. PubMed ID: 11415999
[TBL] [Abstract][Full Text] [Related]
29. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.
Wood TJ; Sliva D; Lobie PE; Goullieux F; Mui AL; Groner B; Norstedt G; Haldosén LA
Mol Cell Endocrinol; 1997 Jun; 130(1-2):69-81. PubMed ID: 9220023
[TBL] [Abstract][Full Text] [Related]
30. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
[TBL] [Abstract][Full Text] [Related]
31. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
33. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) modulates lactogenic hormone-mediated differentiation and gene expression in HC11 mouse mammary epithelial cells.
Shan L; Rouhani SA; Schut HA; Snyderwine EG
Cell Growth Differ; 2001 Dec; 12(12):649-56. PubMed ID: 11751460
[TBL] [Abstract][Full Text] [Related]
34. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
Bernichtein S; Kinet S; Jeay S; Llovera M; Madern D; Martial JA; Kelly PA; Goffin V
Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
[TBL] [Abstract][Full Text] [Related]
35. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
37. Regulation of mammary gland factor/Stat5a during mammary gland development.
Kazansky AV; Raught B; Lindsey SM; Wang YF; Rosen JM
Mol Endocrinol; 1995 Nov; 9(11):1598-609. PubMed ID: 8584036
[TBL] [Abstract][Full Text] [Related]
38. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
39. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
[TBL] [Abstract][Full Text] [Related]
40. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.
Brockman JL; Schuler LA
Mol Cell Endocrinol; 2005 Jul; 239(1-2):45-53. PubMed ID: 15885880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
